awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-22DB5A5E-13D1-43A3-83A3-9828A42A595E
Q33397131-22DB5A5E-13D1-43A3-83A3-9828A42A595E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-22DB5A5E-13D1-43A3-83A3-9828A42A595E
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P2093
Q33397131-22DB5A5E-13D1-43A3-83A3-9828A42A595E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-22DB5A5E-13D1-43A3-83A3-9828A42A595E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a52baaf6bf2ff2e1ccbb54dc8f301578e0ce683
P1545
2
http://www.w3.org/2001/XMLSchema#string
P2093
F Amant
http://www.w3.org/2001/XMLSchema#string